ADRX, Inc. — Form D/A
ADRX, Inc. of THOUSAND OAKS, CA, a company, filed a Form D amendment with the SEC on 2020-10-13. The offering totals $2.6M, of which $2.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-10-13
- Form: D/A
- Accession: 0001826290-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.6M
- Amount sold: $2.6M
- Minimum investment: $25K
- Investors: 19
- Date of first sale: 2013-09-02
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-376953
Issuer
- Name: ADRX, Inc.
- CIK: 0001826290
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 515 MARIN STREET, THOUSAND OAKS, CA, 91360
- Phone: 805-497-2379
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Doug Lane | Executive Officer | Thousand Oaks, CA |
| John Frank | Director | Los Angeles, CA |
| David Wilcox | Executive Officer | Miami, FL |
| Madhavan Balachandran | Director | Agoura Hills, CA |
| Madhavan Balachandran | Executive Officer | Agoura Hills, CA |
| Reza Halse | Director | Somerville, MA |
| Gary Wilcox | Director | Thousand Oaks, CA |
| Marcin Apostol | Executive Officer | Thousand Oaks, CA |
| James Treanor | Director | Thousand Oaks, CA |
Other filings by this issuer (4)
More